What is Novavax's net income?

Novavax (NVAX) reported net income of -$9.49M in Q1 2026.

How has Novavax's net income changed year-over-year?

Novavax's net income decreased by 101.8% year-over-year, from $518.65M to -$9.49M.

What is the long-term trend for Novavax's net income?

Over 4 years (2021 to 2025), Novavax's net income has grown at a -29.1% compound annual growth rate (CAGR), from -$1.74B to $440.3M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Novavax NVAX Net Income

Net Income at other companies

ModernaMRNA

-$1.34B-38.3%

Roivant SciencesROIV

-$265.89M-257%

Merck & Co.MRK

-$4.24B-183%

Vaxcyte, Inc.PCVX

-$320.62M-128%

Viridian Therapeutics, Inc.VRDN

-$104.9M-20.7%

ALN

Alnylam PharmaceuticalsALNY

$205.99M+1,229%

Segments

By segment

See full

Reportable Segment-$9.49M-102%

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+28.6%

Enterprise value$1.53B+68.6%

P/S2.5×+1.5×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's net income?: Novavax (NVAX) reported net income of -$9.49M in Q1 2026.
How has Novavax's net income changed year-over-year?: Novavax's net income decreased by 101.8% year-over-year, from $518.65M to -$9.49M.
What is the long-term trend for Novavax's net income?: Over 4 years (2021 to 2025), Novavax's net income has grown at a -29.1% compound annual growth rate (CAGR), from -$1.74B to $440.3M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.